Search Results factor viia
1.
Use of Recombinant Factor VIIa for Adjunctive Hemorrhage Control in Trauma and Surgical Patients
Recombinant factor VIIa (rFVIIa) has recently been described for patients with ongoing massive bleeding in a number of different clinical scenarios. A...
September 1, 2005; The American Surgeon
2.
Neose Receives Milestone Payment From Novo Nordisk on Factor VIIa Program.
...TM] technology to develop a next-generation version of Factor VIIa. The Company is also working with Novo Nordisk to develop...not be successful, or that a next-generation version of Factor VIIa will not be successfully developed. For a discussion...
November 27, 2006; Business Wire
3.
Neose Announces Two Abstracts on GlycoPEGylated Factor VIIa Accepted for the XXI Congress of the International Society on Thrombosis and Haemostasis.
...abstracts submitted by the Company's collaborative partner, Novo Nordisk A/S, relating to GlycoPEGylated recombinant Factor VIIa have been accepted for poster presentations at the XXIst Congress of the International Society on Thrombosis and Haemostatis...
April 20, 2007; Business Wire
4.
Achieves Milestone in Alliance with Roche for Factor VIIa Therapeutics.
...Roche to co-develop next-generation factor VIIa therapeutics. Maxygen has achieved...a manufacturing process for its factor VIIa product candidates. In December...and commercialize next-generation factor VIIa products for multiple indications...
May 9, 2006; PR Newswire
5.
Treatment of Bleeding in Severe Hemorrhagic Pancreatitis with Recombinant Factor VIIa
Recombinant factor VIIa (rFVIIa) has been used to treat bleeding...pancreatitis treated with rFVIIa. RECOMBINANT FACTOR VIIA (RPVIIA) has recently been developed...patients with hemophilia.1 Recombinant factor VIIa forms a complex with released tissue...
November 1, 2003; The American Surgeon
6.
Transfusion need reduced with injection of factor VIIa. (news: clinical digest: a weekly round-up of the latest research and scientific reports from the nursing and medical journals).(Brief Article)
...Recombinant activated factor VII (factor VIIa) has prohaemostatic effects in...investigated the effects of giving factor VIIa to patients undergoing retropubic...injection of 20 or 40[micro]g/kg of factor VIIa or placebo early in the operation...
February 26, 2003; Nursing Standard
7.
se I Clinical Trial of Long-Acting Factor VIIa.
...clinical trial of GlycoPEGylated Factor VIIa, a long-acting version of NovoSeven[R] Coagulation Factor VIIa (Recombinant). The trial will assess...pharmacokinetics of GlycoPEGylated Factor VIIa in healthy volunteers. GlycoPEGylated...
June 15, 2007; Business Wire
8.
Maxygen Gets Approval for Clinical Trial of Factor VIIa in the UK.
...Approval for Clinical Trial of Factor VIIa in the UK(C)2008 - CloseUpMedia...is the company s next-generation Factor VIIa protein for the treatment of hemophilia...MAXY-VII is designed to be an improved Factor VIIa for the treatment of hemophilia...
June 13, 2008; Health & Beauty Close-Up
9.
Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma
Abstract Activated recombinant factor VIIa was administered to a preterm infant...the following day. Recombinant factor VIIa can be a choice in selected cases...replacement therapy. Keywords: Factor VIIa, preterm, bleeding diasthesis Case...
August 1, 2007; Journal of Maternal - Fetal & Neonatal Medicine
10.
Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia.
...second-generation variant of human coagulation factor VIIa, as a development candidate for...compared with the marketed recombinant factor VIIa product, NovoSeven(R) and a competing...patients in 2009. Patients receiving factor VIIa therapy typically require multiple...
May 6, 2008; PR Newswire
|
